Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besivance vs Vigamox PK in cataract surgery
NCT01296191Phase 4Completed
- Start
- May 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of besifloxacin in endophthalmitis. Primary endpoint: Pharmacokinetics in Aqueous Humor Samples at 3 days. Started May 2011; status: completed.
02
Drugs
besifloxacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT01296191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296191.